Mark J Gergen Insider Trading
Get free email notifications about insider trading for Mark J Gergen.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark J Gergen. Mark J Gergen is a Sr VP Corporate Development in AMYLIN PHARMACEUTICALS INC ($AMLN) and a Sr VP, Corporate Development in AMYLIN PHARMACEUTICALS INC ($AMLN) and a SVP Corporate Development in AMYLIN PHARMACEUTICALS INC ($AMLN) and a SVP, Corporate Development in AMYLIN PHARMACEUTICALS INC ($AMLN) and a SVP, Chief Operating Officer in HALOZYME THERAPEUTICS INC ($GYHT) and an Executive VP, COO in Mirati Therapeutics, Inc. ($MYG) and a President and CBO in Poseida Therapeutics, Inc. ($PSTX).
Address: 9360 TOWNE CENTRE DR SAN DIEGO 92121 CA
Companies in which Mark J Gergen is an Insider
AMYLIN PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mark J Gergen: SVP, Corporate Development, SVP Corporate Development, Sr VP Corporate Development, Sr VP, Corporate Development
Holdings: 0 shares
Latest Transaction: Aug 10 2012
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
HALOZYME THERAPEUTICS, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Mark J Gergen: SVP, Chief Operating Officer
Holdings: 0 shares
Latest Transaction: Sep 02 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Mirati Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mark J Gergen: Executive VP, COO
Holdings: 5,748 shares
Latest Transaction: Jan 26 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Poseida Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Mark J Gergen: President and CBO
Holdings: 0 shares
Latest Transaction: Feb 05 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Mark J Gergen
Sentiment: All, AMLN, GYHT, MYG, PSTX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 05 2021 | PSTX | Poseida Therapeuti ... | Gergen Mark J | President and CBO | Option Exercise | A | 9.15 | 342,000 | 3,129,300 | 342,000 | |
| Feb 05 2021 | PSTX | Poseida Therapeuti ... | Gergen Mark J | President and CBO | Option Exercise | A | 9.15 | 342,000 | 3,129,300 | 342,000 | |
| Jul 13 2020 | PSTX | Poseida Therapeuti ... | Gergen Mark J | President and CBO | Option Exercise | A | 16.00 | 75,000 | 1,200,000 | 75,000 | |
| Sep 02 2016 | GYHT | HALOZYME THERAPEUT ... | Gergen Mark J | SVP, Chief Operatin ... | Option Exercise | A | 9.97 | 333,890 | 3,328,883 | 333,890 | |
| Jan 26 2016 | MYG | Mirati Therapeutic ... | Gergen Mark J | Executive VP, COO | Option Exercise | A | 24.99 | 60,000 | 1,499,400 | 60,000 | |
| Jan 19 2016 | MYG | Mirati Therapeutic ... | Gergen Mark J | Executive VP, COO | Option Exercise | M | 8.50 | 10,000 | 85,000 | 117,000 | |
| Jan 19 2016 | MYG | Mirati Therapeutic ... | Gergen Mark J | Executive VP, COO | Option Exercise | M | 8.50 | 5,000 | 42,500 | 127,000 |